Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorThe Lymphoma Academic Research Organisation
About this trial
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.
Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).
This registry is opened in France and in Belgium
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients with an anaplastic large cell lymphoma associated with breast implants
Disqualifiers
None
Trial population
Adult patients with an anaplastic large cell lymphoma associated with breast implants
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
BIA-ALCL
Other interventionObservational : no intervention
Treatment groups
150 Participants
are divided into 1 treatment groupGroup A: BIA-ALCL1 intervention
Trial outcomes
Primary outcomes
1
Overall response
Time frame
13 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov